Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8872 |
High Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8473 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.838 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8378 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8345 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8322 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8322 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8321 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.8311 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8276 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8273 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8273 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8267 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8267 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8252 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8231 |
Intermediate Similarity |
NPD920 |
Approved |
0.8222 |
Intermediate Similarity |
NPD2797 |
Approved |
0.8219 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8188 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8169 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8105 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8099 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8082 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8071 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8069 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8056 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8056 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8015 |
Intermediate Similarity |
NPD3225 |
Approved |
0.8 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7986 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7973 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7972 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7958 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7958 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7956 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7956 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7922 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7914 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7868 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7847 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7847 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7799 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7793 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7793 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7793 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7792 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7786 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7755 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7742 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7737 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7733 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7733 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7733 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7724 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7707 |
Intermediate Similarity |
NPD919 |
Approved |
0.7703 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7698 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7692 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7676 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7676 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7632 |
Intermediate Similarity |
NPD5403 |
Approved |
0.763 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.763 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7616 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7616 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7562 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7561 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7535 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7519 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7518 |
Intermediate Similarity |
NPD17 |
Approved |
0.7517 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7482 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7468 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7467 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7453 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7444 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7442 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7439 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7432 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7419 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD3226 |
Approved |
0.741 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7403 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7379 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7338 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD5494 |
Approved |
0.732 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7317 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD411 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7292 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7286 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7279 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7273 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.726 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7254 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7252 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7244 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7241 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7241 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7234 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7226 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7202 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7197 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7183 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7178 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7178 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7162 |
Intermediate Similarity |
NPD1933 |
Approved |
0.716 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6502 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6652 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7125 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7105 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7083 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7078 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7075 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7071 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7071 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7063 |
Intermediate Similarity |
NPD37 |
Approved |
0.7062 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7042 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7037 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7037 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7037 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7029
|
Intermediate Similarity |
NPD7157 |
Approved |